Evotec SE has appointed Dr. Sarah Fakih as Executive Vice President, Head of Global Communications and Investor Relations.

As data volumes accelerate, AI is becoming deeply embedded in safety operations and local qualified persons for PV are ...

Hoth Therapeutics has filed two U.S. provisional patent applications that significantly expand its intellectual property ...

Emmaus has granted NeoImmuneTech Inc. an exclusive license to all rights to market, sell and distribute Endari and any ...

BioMarin adds scale of operations, including global commercial footprint and in-house manufacturing capabilities for rare ...

Harbour BioMed, a global biopharmaceutical company, has entered a long-term strategic collaboration with Yantai Lannacheng Biotechnology Co., Ltd.

Novo Nordisk received approval from the U.S. FDA for the Wegovy pill (once-daily oral semaglutide 25 mg) to reduce excess ...

Transcenta Therapeutics, a global biopharmaceutical company with capabilities in discovery, research, development and ...

Akari Therapeutics, Plc, an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads, ...

Rectify Pharmaceuticals has entered a strategic research and licensing agreement with Boehringer Ingelheim to accelerate the ...

Samsung Biologics America, a subsidiary of Samsing Biologics, a CDMO, has entered into a definitive agreement to acquire 100% ...

What defined pharma in 2025? Contract Pharma’s most‑viewed breaking news offers insights. Here’s your yearly recap—the most ...